Trial
NCT04529499
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Dr. Reddy's Laboratories Limited
Collaborators
—
Condition
Covid19
Intervention
AVIGAN
Why stopped
Study met pre-defined criteria for futility at interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-21